Pulmatrix (PULM)
(Delayed Data from NSDQ)
$2.02 USD
0.00 (0.00%)
Updated Apr 24, 2024 02:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PULM 2.02 0.00(0.00%)
Will PULM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PULM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PULM
Pulmatrix, Inc. (PULM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
HOOKIPA Pharma Inc. (HOOK) Reports Q2 Loss, Lags Revenue Estimates
PULM: What are Zacks experts saying now?
Zacks Private Portfolio Services
UniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
Amicus Therapeutics (FOLD) Reports Q3 Loss, Misses Revenue Estimates
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Other News for PULM
PULM Stock Earnings: Pulmatrix Beats EPS, Beats Revenue for Q4 2023
Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update
Pulmatrix GAAP EPS of -$3.87, revenue of $7.3M
Pulmatrix Shifts to Outsourced CMO Model, Terminates Executive
Pulmatrix to Present at Investor Conferences, Limits Updates